Last reviewed · How we verify

Biotest — Portfolio Competitive Intelligence Brief

Biotest pipeline: 0 marketed, 0 filed, 9 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 9 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Trimodulin Trimodulin phase 3 Other
Zutectra Zutectra phase 3 Other
BT524 BT524 phase 3 Monoclonal antibody (anti-TFPI) Tissue Factor Pathway Inhibitor (TFPI) Hematology
BT595 BT595 phase 3 Monoclonal antibody (anti-TFPI) Tissue Factor Pathway Inhibitor (TFPI) Hematology
Placebo (human albumin 1%) Placebo (human albumin 1%) phase 3 Plasma volume expander / Colloid Critical Care / Hematology
BT524 (Part II) BT524 (Part II) phase 3 Monoclonal antibody (anti-TFPI) Tissue Factor Pathway Inhibitor (TFPI) Hematology
BT524 (Part I) BT524 (Part I) phase 3 Monoclonal antibody (anti-TFPI) Tissue Factor Pathway Inhibitor (TFPI) Hematology
IgG Next Generation (BT595) IgG Next Generation (BT595) phase 3 Intravenous immunoglobulin (IVIG) Immunology
FFP/Cryo FFP/Cryo phase 3 Blood product / Hemostatic agent Hematology / Critical Care

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Baxalta now part of Shire · 2 shared drug classes
  2. CSL Behring · 2 shared drug classes
  3. Alexion Pharmaceuticals, Inc. · 1 shared drug class
  4. Arbeitsgemeinschaft medikamentoese Tumortherapie · 1 shared drug class
  5. Assistance Publique - Hôpitaux de Paris · 1 shared drug class
  6. Azienda Ospedaliera Universitaria Integrata Verona · 1 shared drug class
  7. Amgen · 1 shared drug class
  8. AgeneBio · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Biotest:

Cite this brief

Drug Landscape (2026). Biotest — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/biotest. Accessed 2026-05-14.

Related